DK1296669T3 - Combination preparation of omega-3 fatty acids and conjugated linoleic acids for the treatment of immunologically imaged disease images - Google Patents

Combination preparation of omega-3 fatty acids and conjugated linoleic acids for the treatment of immunologically imaged disease images

Info

Publication number
DK1296669T3
DK1296669T3 DK01929617T DK01929617T DK1296669T3 DK 1296669 T3 DK1296669 T3 DK 1296669T3 DK 01929617 T DK01929617 T DK 01929617T DK 01929617 T DK01929617 T DK 01929617T DK 1296669 T3 DK1296669 T3 DK 1296669T3
Authority
DK
Denmark
Prior art keywords
omega
acids
immunologically
imaged
treatment
Prior art date
Application number
DK01929617T
Other languages
Danish (da)
Inventor
Klaus Sommermeyer
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7640945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1296669(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Application granted granted Critical
Publication of DK1296669T3 publication Critical patent/DK1296669T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Abstract

The invention relates to the combined use of omega -3-fatty acids and/or their derivatives and of conjugated linoleic acids (CLA) and/or derivatives thereof for producing a preparation for use against clinical signs with pronounced immunological components.
DK01929617T 2000-05-05 2001-05-03 Combination preparation of omega-3 fatty acids and conjugated linoleic acids for the treatment of immunologically imaged disease images DK1296669T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10022001 2000-05-05

Publications (1)

Publication Number Publication Date
DK1296669T3 true DK1296669T3 (en) 2006-04-18

Family

ID=7640945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01929617T DK1296669T3 (en) 2000-05-05 2001-05-03 Combination preparation of omega-3 fatty acids and conjugated linoleic acids for the treatment of immunologically imaged disease images

Country Status (7)

Country Link
EP (1) EP1296669B1 (en)
AT (1) ATE312604T1 (en)
AU (1) AU2001256334A1 (en)
DE (1) DE50108392D1 (en)
DK (1) DK1296669T3 (en)
ES (1) ES2250397T3 (en)
WO (1) WO2001085161A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329839A1 (en) * 2003-06-04 2005-01-05 Hogl, Peter Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0637957B1 (en) * 1992-04-28 1997-07-23 Fresenius AG Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases
DE4432633C2 (en) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmaceutical preparation for the local treatment of psoriasis, atopic dermatitis and eczema
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
NZ503398A (en) * 1997-08-18 2002-06-28 Univ South Dakota Dairy products with enhanced conjugated linoleic acid content derived from milk of ruminants fed with fish oil

Also Published As

Publication number Publication date
AU2001256334A1 (en) 2001-11-20
ES2250397T3 (en) 2006-04-16
ATE312604T1 (en) 2005-12-15
DE50108392D1 (en) 2006-01-19
EP1296669A1 (en) 2003-04-02
EP1296669B1 (en) 2005-12-14
WO2001085161A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
PT1310249E (en) UTILIZATION OF POLY-INSATURATED FATTY ACIDS FOR PRIMARY PREVENTION OF SERIOUS CARDIOVASCULAR EVENTS
NO20020090L (en) Pharmaceutical and nutritional formulations containing essential fatty acids and homocysteine-lowering agents
HUP0301107A2 (en) Therapeutic combinations of fatty acids and their use
DE69212879D1 (en) Gastric juice-stable pharmaceutical formulations for the oral administration of bile acids
ES2194107T3 (en) PHARMACEUTICAL AND DIETETIC FORMULATIONS FOR PROFILAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS.
BR0110664A (en) Disposable edible fat composition, and, use of a combination of a citric acid ester of partial fatty acid glycerides and a salt
WO2001051008A3 (en) Selective activation of a th1 or th2 lymphocyte regulated immune response
RU2003105901A (en) ANTI-INFLAMMATORY MEDICINE
DK1296669T3 (en) Combination preparation of omega-3 fatty acids and conjugated linoleic acids for the treatment of immunologically imaged disease images
FR2843124B1 (en) PROCESS FOR THE PREPARATION OF FREE POLYUNSATURATED FATTY ACIDS AND THEIR OXIDATION METABOLITES
DE60143052D1 (en) LIPID OF CARBOXYLIC ACID
ATE256654T1 (en) CLA-ESTERS
DE60329588D1 (en) USE OF EPA AND DHA FOR SECONDARY PREVENTION OF STROKE
HUP0301831A2 (en) Use of bioactive metabolites of gepirone for the treatment of psychological disorders
IT1292126B1 (en) WAX ESTERS ENRICHED IN UNSATURATED OMEGA-3 FATTY ACIDS, THEIR PREPARATION AND USE
ES2060440T3 (en) DERIVATIVES OF 1,4-DIHIDROPIRIDIN-DICARBOXILICOS ACIDS ARIL-QUINOLIL SUBSTITUTED, PROCEDURE FOR ITS MANUFACTURE AND ITS USE IN MEDICINES.
ATE387209T1 (en) ORAL INGESTED PREPARATION OF MISTLE ECTINS AND METHOD
SE8304331D0 (en) PHARMACEUTICAL WITH ANALGETIC EFFECT
TH61532S (en) sanitary napkin
ITFO20000009U1 (en) SYSTEM AND INSTRUCTIONS FOR THE ILLUMINATION OF THE SIGNS.
DE502092T1 (en) ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLAMMABLE DISEASES.
ATA13362001A (en) HORMONE PREPARATION WITH UNSATURATED FATTY ACIDS
TH51132S (en) ring
IT1319866B1 (en) SYSTEM AND INSTRUCTIONS FOR THE LIGHTING OF THE SIGNS.
TH85451S (en) Sanitary pads